Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

PHGE.WS BIOMX INC C/WTS 16/10/2024 (TO PUR COM)

Watchlist
0.037
-0.001-2.40%
Close 10/04 16:00 ET
Giving away premium quotes worth 5000 HKD/year to unlock more data
Get NOW
High
0.038
Open
0.038
Turnover
324
Low
0.037
Pre Close
0.038
Volume
8.72K
Market Cap
0
P/E(TTM)
0.00
52wk High
0.518
Shares
0
P/E(Static)
0.00
52wk Low
0.019
Float Cap
0
Bid/Ask %
5.26%
Historical High
0.518
Shs Float
0
Volume Ratio
1.30
Historical Low
0.019
Dividend TTM
--
Div Yield TTM
--
P/B
0.00
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.00%
Amplitude
2.40%
Avg Price
0.037
Lot Size
1
Float Cap
0
Bid/Ask %
5.26%
Historical High
0.518
Shs Float
0
Volume Ratio
1.30
Historical Low
0.019
Dividend TTM
--
P/B
0.00
Dividend LFY
--
Turnover Ratio
0.00%
Amplitude
2.40%
Avg Price
0.037
Lot Size
1
Price Forecast

No Data

News

Comment

No Data

Company Overview More
BiomX, Inc. operates as a clinical-stage microbiome company. It engages in developing both natural and engineered phage cocktails designed to target and destroy harmful bacteria in chronic diseases, such as cystic fibrosis, inflammatory bowel disease, atopic dermatitis, and colorectal cancer. The firm discovers and validates proprietary bacterial targets and customizes phage compositions against these targets. The company was founded in March 2015 and is headquartered in Ness Ziona, Israel.
CEO: --
Market: AMEX
Futu Hot List
USHKCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist
Back to the Top